Screener
Cullinan Therapeutics, Inc. CGEM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Short-term investments | 255,898 | 289,564 |
| Prepaid expenses and other current assets | 7,436 | 8,860 |
| Total current assets | 341,974 | 386,756 |
| Property and equipment, net | 263 | 421 |
| Operating lease right-of-use assets | 2,233 | 2,630 |
| Other assets | 297 | 297 |
| Long-term investments | 19,020 | 58,270 |
| Total assets | $363,787 | $448,374 |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s PP&E (net)?
- Cullinan Therapeutics, Inc. (CGEM) reported PP&E (net) of $263K in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Cullinan Therapeutics, Inc.'s PP&E (net) decreased by 53.8% year-over-year, from $569K to $263K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s PP&E (net) has grown at a 26.5% compound annual growth rate (CAGR), from $130K to $421K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Cullinan Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude